共 50 条
- [1] Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter TrialAMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (02) : 129 - 138Sohn, Il SukKim, Chong-JinOh, Byung-HeeHong, Taek-JongPark, Chang-GyuKim, Byung-SooChung, Woo-Baek
- [2] Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter TrialAmerican Journal of Cardiovascular Drugs, 2016, 16 : 139 - 139Il Suk SohnChong-Jin KimByung-Hee OhTaek-Jong HongChang-Gyu ParkByung-Soo KimWoo-Baek Chung
- [3] Combination Therapy with Olmesartan Medoxomil and Hydrochlorothiazide Secondary Analysis of the Proportion of Patients Achieving Recommended Blood Pressure Goals from a Randomized, Double-Blind, Factorial StudyAMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (04) : 241 - 251Chrysant, Steven G.Chavanu, Kathleen J.Xu, Jianbo
- [4] Secondary analysis of the distribution of blood pressure reductions in patients receiving olmesartan medoxomil and hydrochlorothiazide in a factorial-design studyJOURNAL OF HYPERTENSION, 2007, 25 : S380 - S380Chrysant, S.Xu, J.Dubiel, R.
- [5] TREATMENT OF AMBULATORY HYPERTENSIVES WITH NEBIVOLOL OR HYDROCHLOROTHIAZIDE ALONE AND IN COMBINATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FACTORIAL-DESIGN TRIALAMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (02) : 137 - 145LACOURCIERE, YLEFEBVRE, JPOIRIER, LARCHAMBAULT, FARNOTT, A
- [6] Correlation between blood pressure reduction and baseline blood pressure in patients receiving olmesartan medoxomil and/or hydrochlorothiazide in a factorial-design studyJOURNAL OF HYPERTENSION, 2007, 25 : S380 - S381Chrysant, S.Xu, J.Dubiel, R.
- [7] A Randomized, Double-Blind, Forced-Titration Study to Compare Olmesartan Medoxomil Versus Losartan Potassium in Patients with Stage 1 and 2 HypertensionPOSTGRADUATE MEDICINE, 2011, 123 (01) : 80 - 87Weir, Matthew R.Punzi, Henry A.Flack, John M.Stoakes, Kathy A.Chavanu, Kathleen J.Li, WeiDubiel, Robert
- [8] Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double-Blind StudyNEW FRONTIERS IN HEART DISEASE, 2011, : 183 - 196Black, Henry R.Kribben, AndreasPalacios, Fernando AguirreBijarnia, MahendraLaflamme, Annik K.Baschiera, Fabio
- [9] Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double-Blind StudyJOURNAL OF CLINICAL HYPERTENSION, 2010, 12 (12): : 917 - 926Black, Henry R.Kribben, AndreasAguirre Palacios, FernandoBijarnia, MahendraLaflamme, Annik K.Baschiera, Fabio
- [10] Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2599 - 2609Park, Jin-SunShin, Joon-HanHong, Taek-JongSeo, Hong-SeogShim, Wan-JooBaek, Sang-HongJeong, Jin-OkAhn, YoungkeunKang, Woong-CholKim, Young-HakKim, Sang-HyunHyon, Min-SuChoi, Dong-HoonNam, Chang-WookPark, Tae-HoLee, Sang-CholKim, Hyo-Soo